首页> 外文期刊>Molecular cell >Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program
【24h】

Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program

机译:解雇RNA聚合酶II是大型配体诱导的增强剂退役计划

获取原文
获取原文并翻译 | 示例
           

摘要

Nuclear receptors induce both transcriptional activation and repression programs responsible for development, homeostasis, and disease. Here, we report a previously overlooked enhancer decommissioning strategy underlying a large estrogen receptor alpha (ERα)-dependent transcriptional repression program. The unexpected signature for this E2-induced program resides in indirect recruitment of ERα to a?large cohort of pioneer factor basally active FOXA1-bound enhancers that lack cognate ERα DNA-binding?elements. Surprisingly, these basally active estrogen-repressed (BAER) enhancers are decommissioned by ERα-dependent recruitment of the histone demethylase KDM2A, functioning independently of its demethylase activity. Rather, KDM2A tethers the E3 ubiquitin-protein ligase NEDD4 to ubiquitylate/dismiss Pol II to abrogate eRNA transcription, with consequent target gene downregulation. Thus, our data reveal that Pol II ubiquitylation/dismissal may serve as a potentially broad strategy utilized by indirectly bound nuclear receptors to abrogate large programs of pioneer factor-mediated, eRNA-producing enhancers.
机译:核受体诱导负责发育,稳态和疾病的转录激活和抑制方案。在这里,我们报告了一个以前被忽视的增强剂退役策略,潜在的大雌激素受体α(ERα) - 依赖性转录镇压计划。该E2诱导程序的意外签名驻留在间接招募ERα到A?大队列的先驱因子群体缺乏同源ERαDNA结合的增强剂α元素。令人惊讶的是,这些基本活性的雌激素抑制(BAER)增强剂通过ERα依赖性募集的组蛋白脱甲基酶KDM2A退出,独立于其去甲基酶活性而进行。相反,KDM2A将E3泛素 - 蛋白质连接酶NEDD4与ubiquitylate / Dismiss pol II发布到erna转录,随后的靶基因下调。因此,我们的数据揭示了POL II泛力/解雇可以作为通过间接束缚的核受体利用的潜在广泛的策略,以消除欧洲先驱因子介导的欧尔纳的增强剂。

著录项

  • 来源
    《Molecular cell》 |2018年第4期|共22页
  • 作者单位

    Howard Hughes Medical Institute Department of Medicine University of California;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Stanford University School of Medicine;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Howard Hughes Medical Institute Department of Medicine University of California;

    Department of Structural and Chemical Biology Mount Sinai School of Medicine;

    Howard Hughes Medical Institute Department of Medicine University of California;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;
  • 关键词

    ERα; enhancer; KDM2A; NEDD4; Pol II; transcription; decommission; eRNA; nuclear receptor; repression;

    机译:ERα;Envancer;KDM2A;NEDD4;POL II;转录;退役;erna;核受体;镇压;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号